Expression of KLF4 is a predictive marker for survival in pediatric Burkitt lymphoma

miR-7 Suppresses Brain Metastasis of Breast Cancer Stem-Like Cells By Modulating KLF4

(2013) H. Okuda et al.   CANCER RESEARCH

Shaking the family tree: identification of novel and biologically active alternatively spliced isoforms across the KLF family of transcription factors

(2012) Olga Camacho-Vanegas et al.   FASEB JOURNAL

Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion

(2011) F Yu et al.   ONCOGENE

KLF4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classic Hodgkin lymphoma

(2010) H. Guan et al.   BLOOD

Yin Yang 1 overexpression in diffuse large B-cell lymphoma is associated with B-cell transformation and tumor progression

(2010) Giancarlo Castellano et al.   CELL CYCLE

Oncogenic Activation of NF- B

(2010) L. M. Staudt   Cold Spring Harbor Perspectives in Biology

Prognostic models for diffuse large B-cell lymphoma in the rituximab era: a never-ending story

(2009) A. Bari et al.   ANNALS OF ONCOLOGY

Rituximab-Mediated Cell Signaling and Chemo/Immuno-sensitization of Drug-Resistant B-NHL Is Independent of Its Fc Functions

(2009) M. I. Vega et al.   CLINICAL CANCER RESEARCH

Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4

(2009) C. A. Lyssiotis et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Roles of Krüppel-like factor 4 in normal homeostasis, cancer and stem cells

(2008) Paul M Evans et al.   ACTA BIOCHIMICA ET BIOPHYSICA SINICA

Molecular profiling of pediatric mature B-cell lymphoma treated in population-based prospective clinical trials

(2008) W. Klapper et al.   BLOOD

An Extended Transcriptional Network for Pluripotency of Embryonic Stem Cells

(2008) Jonghwan Kim et al.   CELL

KLF4 is a FOXO target gene that suppresses B cell proliferation

(2008) I. Yusuf et al.   INTERNATIONAL IMMUNOLOGY

Genomic alterations and gene expression in primary diffuse large B-cell lymphomas of immune-privileged sites: the importance of apoptosis and immunomodulatory pathways

(2008) M Booman et al.   JOURNAL OF PATHOLOGY

The expression of 16 genes related to the cell of origin and immune response predicts survival in elderly patients with diffuse large B-cell lymphoma treated with CHOP and rituximab

(2008) J-P Jais et al.   LEUKEMIA